We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Agilent Appoints Ambry Genetics as First CSP for Agilent’s Target Enrichment System for Next-Gen Sequencing

News   Oct 27, 2009

 
Agilent Appoints Ambry Genetics as First CSP for Agilent’s Target Enrichment System for Next-Gen Sequencing
 
 
Advertisement
 

RELATED ARTICLES

New Cancer Drug Targeting DNA Repair Shows Promise in Early-Stage Trial

News

A new precision drug which stops cancer from repairing its DNA has shown promise in an early-stage clinical trial – highlighting the potential of a new class of drugs known as ATR inhibitors.

READ MORE

Anti-Alzheimer's Gene Variant Enhances Immune Cells

News

A new study conducted by researchers at the University of Eastern Finland found that a genetic variant named PLCG2-P522R, which protects against Alzheimer's disease, enhances several key functions of immune cells.

READ MORE

New Drug Could Offer Hope for Muscular Dystrophy Patients

News

A new drug offers hope for young boys with the progressive neuromuscular disease Duchenne muscular dystrophy (DMD) by potentially offering an alternative to high-dose glucocorticoids that have significant side effects.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE